SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-012757
Filing Date
2021-05-24
Accepted
2021-05-24 17:26:34
Documents
102

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 2907458
2 ex5-1.htm EX-5.1 10181
3 ex23-1.htm EX-23.1 4620
4 GRAPHIC ex5-1_001.jpg GRAPHIC 6706
  Complete submission text file 0001493152-21-012757.txt   11467803

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE otlc-20210331.xml EX-101.INS 1741023
6 XBRL SCHEMA FILE otlc-20210331.xsd EX-101.SCH 84137
7 XBRL CALCULATION FILE otlc-20210331_cal.xml EX-101.CAL 90868
8 XBRL DEFINITION FILE otlc-20210331_def.xml EX-101.DEF 703918
9 XBRL LABEL FILE otlc-20210331_lab.xml EX-101.LAB 502536
10 XBRL PRESENTATION FILE otlc-20210331_pre.xml EX-101.PRE 752102
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-256448 | Film No.: 21956288
SIC: 2834 Pharmaceutical Preparations